Ticker Appearances
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 38 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 1d52ba-01fe44-5042c1-de8454-939b9d
Visitor: 1d52ba-01fe44-5042c1-de8454-939b9d Array ( [cookie] => 1d52ba-01fe44-5042c1-de8454-939b9d [current_usage] => 38 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.51 )
Your Weekly Roadmap
Stocks’ Continued Strength Bodes Well For 2nd Half
"An investment in knowledge pays the best interest." — Benjamin Franklin Good evening: For months, our Tom Lee has said inflation would fall throughout 2023...
This report is accessible to FSI Pro, FSI Macro, FSI Weekly memberships.
You have viewed the limit of 38 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 1d52ba-01fe44-5042c1-de8454-939b9d
Visitor: 1d52ba-01fe44-5042c1-de8454-939b9d Array ( [cookie] => 1d52ba-01fe44-5042c1-de8454-939b9d [current_usage] => 38 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.51 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 38 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 1d52ba-01fe44-5042c1-de8454-939b9d
Visitor: 1d52ba-01fe44-5042c1-de8454-939b9d Array ( [cookie] => 1d52ba-01fe44-5042c1-de8454-939b9d [current_usage] => 38 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.51 )
Your Weekly Roadmap
Stocks’ Continued Strength Bodes Well For 2nd Half
"An investment in knowledge pays the best interest." — Benjamin Franklin Good evening: For months, our Tom Lee has said inflation would fall throughout 2023...
This report is accessible to FSI Pro, FSI Macro, FSI Weekly memberships.
You have viewed the limit of 38 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 1d52ba-01fe44-5042c1-de8454-939b9d
Visitor: 1d52ba-01fe44-5042c1-de8454-939b9d Array ( [cookie] => 1d52ba-01fe44-5042c1-de8454-939b9d [current_usage] => 38 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.51 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 38 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 1d52ba-01fe44-5042c1-de8454-939b9d
Visitor: 1d52ba-01fe44-5042c1-de8454-939b9d Array ( [cookie] => 1d52ba-01fe44-5042c1-de8454-939b9d [current_usage] => 38 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.51 )
Articles Read 2/2
🎁 Unlock 1 extra article by joining our Community!
You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.
Already have an account? Sign In 1d52ba-01fe44-5042c1-de8454-939b9d
Already have an account? Sign In 1d52ba-01fe44-5042c1-de8454-939b9d